New York, New York--(Newsfile Corp. - November 7, 2022) - ANEW MEDICAL, INC., (OTC Pink: LEAS), today announced that they will be attending the Q4 Investor Summit live in NYC at the Sheraton Times Square. During the presentation, Dr. Joseph Sinkule, CEO and Founder of ANEW MEDICAL, INC., will describe the business model and strategy for the commercialization of drugs, biologics, and gene therapies targeting major diseases confronting mankind. An overview of the two corporate divisions - generics/biogenerics and gene/cell therapies - will be discussed and the value of this two-stage approach and corporate vision will be laid out. The presentation will be "in person" and the live webcast will be made available in the Investors' section of the www.anewmeds.com website.
Event:Q4 Investor Summit
Date: November 14th, 2022
Presentation:November 14th at 10:30 AM ET
Location: Sheraton New York Times Square Hotel, 811 7th Avenue, W 53rd St, New York, NY 10019
Webcast:https://us06web.zoom.us/webinar/register/WN_gFoy6fVGQ0yIRo-e7eDKgA
About ANEW MEDICAL, INC.
ANEW MEDICAL, INC. (ANEW) is a publicly listed (OTC Pink: LEAS) biotechnology company with offices and laboratories in the US and in Spain, committed to the development of diagnostics and therapies for the benefit of the world's ever increasing elderly population and the multiple age-related disorders from which they suffer. We are currently seeking equity-based funding to develop two platforms of medicines 1. life-saving generic oncology drugs and biogeneric biosimilar antibodies for cancer and other age-related conditions, and 2. proprietary Klotho-based diagnostics that identifies persons who are at risk for age-related pathologies and gene/cell therapeutic product candidates to correct the deficiency of Klotho. Revenue from the generic and biogeneric drug sales in 2023 and 2024 will help to fuel the development of multiple, proprietary cell and gene therapy products incorporating the patented Klotho gene and protein expression system.
Company Contact:
Joseph Sinkule, CEO and Founder
ANEW MEDICAL, INC.
jasinkule@gmail.com
www.anewmeds.com
About Investor Summit Group
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q4 Investor Summit will take place in-person and virtually, featuring 50+ companies and over 300 investors comprised of institutional investors, family offices, and high net worth investors. Sectors Participating: Biotech, Communication Services, Consumer, Energy, Energy/Tech, Financial, Healthcare, Industrials, Materials, Real Estate, Technology, and Tech/Crypt. Contact: info@investorsummitgroup.com.
------------------------------------------------------------------------------------------------------------------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/143229
